Larimar Therapeutics logo

Larimar Therapeutics Share Price (NASDAQ: LRMR)

$3.62

-0.29

(-7.42%)

Last updated on

Check the interactive Larimar Therapeutics Stock chart to analyse performance

Larimar Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$3.60
    Today's High:$3.97

    Day's Volatility :9.32%

  • 52 Weeks Low:$1.61
    52 Weeks High:$9.50

    52 Weeks Volatility :83.05%

Larimar Therapeutics Stock Returns

PeriodLarimar Therapeutics IncIndex (Russel 2000)
3 Months
65.08%
0.0%
6 Months
37.36%
0.0%
1 Year
-47.4%
0.0%
3 Years
41.09%
-4.7%

Larimar Therapeutics Inc Key Stats

Check Larimar Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.91
Open
$3.93
Today's High
$3.97
Today's Low
$3.6
Market Capitalization
$334.7M
Today's Volume
$1.4M
52 Week High
$9.5
52 Week Low
$1.61
Revenue TTM
$0.0
EBITDA
$-108.2M
Earnings Per Share (EPS)
$-1.57
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-60.25%

Stock Returns calculator for Larimar Therapeutics Stock including INR - Dollar returns

The Larimar Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Larimar Therapeutics investment value today

Current value as on today

₹57,596

Returns

₹42,404

(-42.4%)

Returns from Larimar Therapeutics Stock

₹47,688 (-47.69%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Larimar Therapeutics Stock

520%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Larimar Therapeutics Stock from India on INDmoney has increased by 520% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Larimar Therapeutics Inc

  • Name

    Holdings %

  • Deerfield Management Co

    24.81%

  • RA Capital Management, LLC

    7.06%

  • Blue Owl Capital Holdings LP

    5.76%

  • Opaleye Management Inc

    4.80%

  • BlackRock Inc

    3.65%

  • Vanguard Group Inc

    2.50%

Analyst Recommendation on Larimar Therapeutics Stock

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Larimar Therapeutics(by analysts ranked 0 to 5 stars)

Larimar Therapeutics Share Price Target

What analysts predicted

Upside of 433.15%

Target:

$19.30

Current:

$3.62

Larimar Therapeutics share price target is $19.30, a slight Upside of 433.15% compared to current price of $3.62 as per analysts' prediction.

Larimar Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, LRMR stock has moved down by -6.9%
  • LRMR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 123.9%
  • LRMR vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 81.2%

Larimar Therapeutics Technicals Summary

Sell

Neutral

Buy

Larimar Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Larimar Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Larimar Therapeutics Inc logo
5.2%
37.36%
-47.4%
41.09%
-69.44%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Larimar Therapeutics Inc

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
Organization
Larimar Therapeutics
Employees
65
CEO
Dr. Carole S. Ben-Maimon M.D.
Industry
Health Technology

Key Management of Larimar Therapeutics Inc

NameTitle
Dr. Carole S. Ben-Maimon M.D.
CEO, President & Director
Mr. Michael Celano CPA
Secretary & CFO
Dr. Gopi Shankar M.B.A., Ph.D.
Chief Development Officer
Mr. John Berman
Vice President of Finance & Administration
Ms. Jennifer Spokes Johansson
Vice President of Legal & Compliance
Dr. Russell G. Clayton Sr., D.O, D.O.
Chief Medical Officer
Mr. Francis Michael Conway CPA
VP & Controller

Important FAQs about investing in LRMR Stock from India :

What is Larimar Therapeutics share price today?

Larimar Therapeutics share price today is $3.62 as on at the close of the market. Larimar Therapeutics share today touched a day high of $3.97 and a low of $3.60.

What is the 52 week high and 52 week low for Larimar Therapeutics share?

Larimar Therapeutics share touched a 52 week high of $9.50 and a 52 week low of $1.61. Larimar Therapeutics stock price today i.e. is closed at $3.62, lower by 61.89% versus the 52 week high.

How to invest in Larimar Therapeutics Stock (LRMR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Larimar Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Larimar Therapeutics Shares that will get you 0.4144 shares as per Larimar Therapeutics share price of $3.62 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Larimar Therapeutics Stock (LRMR) from India?

Indian investors can start investing in Larimar Therapeutics (LRMR) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Larimar Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Larimar Therapeutics share’s latest price of $3.62 as on August 30, 2025 at 1:29 am IST, you will get 2.7624 shares of Larimar Therapeutics. Learn more about fractional shares .

What are the returns that Larimar Therapeutics has given to Indian investors in the last 5 years?

Larimar Therapeutics stock has given -69.44% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?